Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public











Title  Creator  Group name  Publishing year 
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA) Wislez et al. EquipeAM 2021-07
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner Bianco et al. EquipeAM 02 22, 2019
Multicenter evaluation of a novel ROS1 immunohistochemistry assay (SP384) for detection of ROS1 rearrangements in a large cohort of lung adenocarcinoma patients Hofman et al. EquipeMY Apr 15, 2019
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort Merveilleux du Vignaux et al. EquipeAM 11 2018
The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism Calvayrac et al. EquipeAM 02 2017
Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches Vendrell et al. EquipePC 10 02, 2017


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés